2022
Title: Inhibidores alostéricos de Fascina como nuevos fármacos antimetastásicos (refs: PY20_00678, B-BIO18-UGR20) FEDER-Junta de Andalucía. Project PI: Irene Luque Fernández. Partner: Pablo Conesa Zamora. 01/01/2022-31/12/2023. 135.000€. Autonomic.
Title: RNA no codificante (ncRNA) como biomarcador de riesgo en la trombosis asociada al cáncer de colon metastásicos. Sociedad Española de Trombosis y Hemostasia. Project PI: Ginés Luengo Gil. 01/01/2022-31/12/2023. 15,000€. National.
Title: Project FEDER UGR_Junta de Andaluacía — B-BIO18-UGR20 — Partner: Pablo Conesa Zamora. Project period: 01/01/2022-31/12/2024. Budget: 35,000€. Autonomic.
Title: Project of excellence of the Junta de Andalucía — PY20_00678— Partner: Pablo Conesa Zamora. Project period: 01/01/2022-31/12/2024. Budget: 100,000€ Autonomic.
2021
Title: Histological and clinical effects of imipramine in the treatment of patients with fascin1-overexpressing tumors (ref: ICI20/00044) Instituto de Salud Carlos III. Project PI: Pablo Conesa Zamora. 01/01/2021- 01/01/2025. 218.900 €. National.
2020
Title: taRgeted thErapy for adVanced colorEctal canceR paTients (REVERT). Ref: SEP-210574932. Funding Institution: Horizon 2020. European Commission. Call: H2020-SC1-BHC-2020-2023. Duration in months: 48. Project IP: Fiorella Guadagi. Partner PI: Pablo Conesa Zamora. Partner Budget: 340,000€. International.
2019
Title: Design and characterization of fascin inhibitors for blockin invasion and metastasis in colorectal cancer. Ref: PI18/00144. Funding Institution: Instituto de Salud Carlos III (Spanish Ministry of Health). Project period: 01/01/2019-31/08/2021. Project IP: Pablo Conesa-Zamora. Budget: 93,170€ National.
Title: Characterization of analogues of novel fascin1 inhibitors for a histology-based treatment of colorectal cancer. Ref: PID:6632. Funding Institution: Corbel program. European Commission. Project period: 01/01/2019-01/08/2021. Project IP: Pablo Conesa-Zamora. Budget: 15,000€ International.
Title: Identificación de nuevos factores implicados en la progresión y complicaciones de Neoplasias Mieloproliferativas Crónicas Philadelphia Negativas. Partner: Ginés Luengo Gil. 20644/JLI/18. 01/01/2019-31/12/2021. National.
2018
2017
Title: Novel fascin inhibitors for the treatment of colorectal serrated adenocarcinoma. Ref: PID: 2428. Funding Institution: Instruct Hub. European Commission. Project period: 01/03/2017-01/08/2019. Project PI: Pablo Conesa-Zamora. Budget: 15,000€ International.
Title: Exploring therapeutic options for serrated and high-grade microsatellite instability colorectal carcinomas. Ref. PID: 2334. Funding Institution: Corbel program. European Commission. Project period: 01/03/2017-01/08/2019. Project PI: Pablo Conesa-Zamora. Budget: 15,000€ International.
Title: Epigenetic aspects of the contribution of microbiota to colorectal cancer development. Ref. PID: 2334. Funding Institution: San Antonio Catholic University. Project period: 01/01/2017-01/08/2019. Project PI: Pablo Conesa-Zamora. Budget: 10,000€. Autonomic.
2016
Title: Estudio del valor de los ácidos nucleicos circulantes en pacientes con cáncer de mama y de próstata avanzado en progresión a hormonoterapia. Partner: Ginés Luengo Gil. PI15/01499. 01/01/2016-30/06/2019. National.
2015
Title: Pharmacological approaches to serrated adenocarcinoma treatment: functional characterization of therapeutic targets and their inhibitors. Ref: PI15/00626. Funding Institution: Instituto de Salud Carlos III (Spanish Ministry of Health). Project period: 01/01/2015-31/12/2019. Project PI: Pablo Conesa-Zamora. Budget: 93,170€. National.